Showing results (11-20 of 64) with videos related to
Sort By:
Pageof 7
FEMS Microbiology Reviews|February 13, 2021
Clostridioides difficile phage biology and applicationJoshua Heuler, Louis-Charles Fortier, Xingmin SunBiomaterials|November 10, 2012
A versatile coiled-coil tethering system for the oriented display of ligands on nanocarriers for targeted gene deliveryCharles Fortier, Gregory De Crescenzo, Yves DurocherNanomedicine (London, England)|December 21, 2013
Surface modification of nonviral nanocarriers for enhanced gene deliveryCharles Fortier, Yves Durocher, Gregory De CrescenzoMethods in Molecular Biology (Clifton, N.J.)|June 9, 2014
Enhanced ELISA based on carboxymethylated dextran coatingsBenoît Liberelle, Charles Fortier, Gregory De CrescenzoJournal of Clinical Microbiology|September 30, 2011
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypesStéphanie Sirard, Louis Valiquette, Louis-Charles FortierApplied and Environmental Microbiology|August 28, 2012
Evidence of in vivo prophage induction during Clostridium difficile infectionMathieu Meessen-Pinard, Ognjen Sekulovic, Louis-Charles FortierJournal of Bacteriology|May 20, 2005
Expression and site-directed mutagenesis of the lactococcal abortive phage infection protein AbiKLouis-Charles Fortier, Julie D Bouchard, Sylvain MoineauBMC Infectious Diseases|January 16, 2014
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactamJulian R Garneau, Louis Valiquette, Louis-Charles FortierJournal of Bacteriology|March 29, 2011
Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogensOgnjen Sekulovic, Mathieu Meessen-Pinard, Louis-Charles FortierPlos Genetics|April 13, 2011
c-di-GMP turn-over in Clostridium difficile is controlled by a plethora of diguanylate cyclases and phosphodiesterasesEric Bordeleau, Louis-Charles Fortier, François Malouin, et al.Pageof 7